Addus HomeCare Stock Forecast, Price & News

Addus HomeCare (NASDAQ:ADUS) Frequently Asked Questions

Is Addus HomeCare a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Addus HomeCare stock.
View analyst ratings for Addus HomeCare or view top-rated stocks.

How has Addus HomeCare's stock price been impacted by Coronavirus (COVID-19)?

Addus HomeCare's stock was trading at $67.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ADUS shares have increased by 32.9% and is now trading at $89.88.
View which stocks have been most impacted by COVID-19.

Are investors shorting Addus HomeCare?

Addus HomeCare saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 516,400 shares, an increase of 20.9% from the October 31st total of 427,200 shares. Based on an average trading volume of 103,700 shares, the days-to-cover ratio is currently 5.0 days. Approximately 3.3% of the company's stock are sold short.
View Addus HomeCare's Short Interest.

When is Addus HomeCare's next earnings date?

Addus HomeCare is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Addus HomeCare.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) announced its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.89 by $0.02. The firm had revenue of $216.66 million for the quarter, compared to analysts' expectations of $227.11 million. Addus HomeCare had a trailing twelve-month return on equity of 8.77% and a net margin of 4.85%. The company's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.69 EPS.
View Addus HomeCare's earnings history.

What price target have analysts set for ADUS?

2 Wall Street analysts have issued 12 month price objectives for Addus HomeCare's stock. Their forecasts range from $115.00 to $124.00. On average, they expect Addus HomeCare's stock price to reach $119.50 in the next year. This suggests a possible upside of 33.0% from the stock's current price.
View analysts' price targets for Addus HomeCare or view top-rated stocks among Wall Street analysts.

Who are Addus HomeCare's key executives?

Addus HomeCare's management team includes the following people:

• R. Dirk Allison, Chairman & Chief Executive Officer (LinkedIn Profile)
• W. Bradley Bickham, President & Chief Operating Officer (LinkedIn Profile)
• Brian W. Poff, CFO, Secretary, Treasurer & Executive VP (LinkedIn Profile)
• Nick Duthie, Vice President-Information Technology
• Michael Wattenbarger, Chief Information Officer & Executive VP (LinkedIn Profile)

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare CEO Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among Addus HomeCare's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Addus HomeCare's key competitors?

Some companies that are related to Addus HomeCare include Amedisys (AMED), Option Care Health (OPCH), LHC Group (LHCG), AdaptHealth (AHCO), Signify Health (SGFY), Aveanna Healthcare (AVAH), Apria (APR), APR Energy (APR), Cancer Treatment (CTHZ) and New York Health Care (BBAL).
View all of ADUS's competitors.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.07%), Capital World Investors (5.90%), Eaton Vance Management (3.80%), Dimensional Fund Advisors LP (3.43%), Principal Financial Group Inc. (3.06%) and Invesco Ltd. (2.95%). Company insiders that own Addus HomeCare stock include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus HomeCare.

Which major investors are selling Addus HomeCare stock?

ADUS stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Royal Bank of Canada, Voya Investment Management LLC, Wasatch Advisors Inc., Marshall Wace LLP, TimesSquare Capital Management LLC, Renaissance Technologies LLC, and Fort Washington Investment Advisors Inc. OH. Company insiders that have sold Addus HomeCare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, and W Bradley Bickham.
View insider buying and selling activity for Addus HomeCare or view top insider-selling stocks.

Which major investors are buying Addus HomeCare stock?

ADUS stock was purchased by a variety of institutional investors in the last quarter, including FIL Ltd, Summit Creek Advisors LLC, BlackRock Inc., Capital World Investors, Eaton Vance Management, NFJ Investment Group LLC, Comerica Bank, and Assenagon Asset Management S.A..
View insider buying and selling activity for Addus HomeCare or or view top insider-buying stocks.

How do I buy shares of Addus HomeCare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $89.88.

How much money does Addus HomeCare make?

Addus HomeCare has a market capitalization of $1.43 billion and generates $764.78 million in revenue each year. The company earns $33.13 million in net income (profit) each year or $2.52 on an earnings per share basis.

How many employees does Addus HomeCare have?

Addus HomeCare employs 35,139 workers across the globe.

What is Addus HomeCare's official website?

The official website for Addus HomeCare is www.addus.com.

Where are Addus HomeCare's headquarters?

Addus HomeCare is headquartered at 6801 GAYLORD PARKWAY, FRISCO TX, 75034.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at (469) 535-8200, via email at [email protected], or via fax at 630-487-2707.